Home / Activity / ImQuest BioSciences (USA)
FINAL TECHNICAL REPORT ANTI-HIV EVALUATION OF FULLERENE-POLY-AMINOCAPROIC ACID
FINAL TECHNICAL REPORT PRECLINICAL ANTI-HIV DRUG DEVELOPMENT OF FULLERENE POLY-AMINO-CAPROIC ACID & appendix I
FINAL TECHNICAL REPORT PRECLINICAL ANTI-HIV DRUG DEVELOPMENT OF FULLERENE POLY-AMINO-CAPROIC ACID appendix II
FINAL TECHNICAL REPORT PRECLINICAL ANTI-HIV DRUG DEVELOPMENT OF FULLERENE POLY-AMINO-CAPROIC ACID appendix III
FINAL TECHNICAL REPORT PRECLINICAL ANTI-HIV DRUG DEVELOPMENT OF FULLERENE POLY-AMINO-CAPROIC ACID ) appendix IV
Anti-HIV Combination Therapy Evaluations
FINAL TECHNICAL REPORT PRECLINICAL SELECTION AND CHARACTERIZATION OF VIRUS STRAINS RESISTANT TO FULLERENE POLY-AMINO-CAPROIC ACID
Mechanism of Anti-HIV Action Evaluation
Activity against an extended panel of define drug-resistant viruses in fresh human PBMCs
PBMC data
